DE69616366D1 - Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen - Google Patents

Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen

Info

Publication number
DE69616366D1
DE69616366D1 DE69616366T DE69616366T DE69616366D1 DE 69616366 D1 DE69616366 D1 DE 69616366D1 DE 69616366 T DE69616366 T DE 69616366T DE 69616366 T DE69616366 T DE 69616366T DE 69616366 D1 DE69616366 D1 DE 69616366D1
Authority
DE
Germany
Prior art keywords
alkyl
halo
aryl
methyl
substd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69616366T
Other languages
English (en)
Other versions
DE69616366T2 (de
Inventor
K Hutchinson
D Ennis
L Hoffman
C Thomas
Toni-Jo Poel
Robert Barbachyn
J Brickner
J Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21704418&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69616366(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69616366D1 publication Critical patent/DE69616366D1/de
Publication of DE69616366T2 publication Critical patent/DE69616366T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69616366T 1995-09-01 1996-08-13 Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen Expired - Fee Related DE69616366T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US314995P 1995-09-01 1995-09-01
PCT/US1996/012766 WO1997009328A1 (en) 1995-09-01 1996-08-13 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings

Publications (2)

Publication Number Publication Date
DE69616366D1 true DE69616366D1 (de) 2001-11-29
DE69616366T2 DE69616366T2 (de) 2002-07-04

Family

ID=21704418

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69616366T Expired - Fee Related DE69616366T2 (de) 1995-09-01 1996-08-13 Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen

Country Status (27)

Country Link
US (7) US5968962A (de)
EP (1) EP0856002B1 (de)
JP (1) JPH11512386A (de)
KR (1) KR100463772B1 (de)
CN (1) CN1072222C (de)
AT (1) ATE207487T1 (de)
AU (1) AU716493B2 (de)
BR (1) BR9610474A (de)
CA (1) CA2228647A1 (de)
CZ (1) CZ49398A3 (de)
DE (1) DE69616366T2 (de)
DK (1) DK0856002T3 (de)
ES (1) ES2165516T3 (de)
FI (1) FI980452A (de)
HK (1) HK1014946A1 (de)
HU (1) HUP9901979A3 (de)
MX (1) MX9801578A (de)
NO (1) NO311520B1 (de)
NZ (1) NZ315469A (de)
PL (1) PL186524B1 (de)
PT (1) PT856002E (de)
RU (1) RU2175324C2 (de)
SK (1) SK283487B6 (de)
TW (1) TW419468B (de)
UA (1) UA52620C2 (de)
WO (1) WO1997009328A1 (de)
ZA (1) ZA966935B (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2175324C2 (ru) * 1995-09-01 2001-10-27 Фармация Энд Апджон Компани Фенилоксазолидиноны, имеющие с-с-связь с 4-8-членными гетероциклическими кольцами
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
WO1999002525A1 (en) * 1997-07-11 1999-01-21 Pharmacia & Upjohn Company Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents
GB9717807D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
US6083967A (en) * 1997-12-05 2000-07-04 Pharmacia & Upjohn Company S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones
EP1049682A1 (de) 1998-01-23 2000-11-08 Versicor, Inc. Oxazolidinone kombinatorische bibliotheken, verfahren zu ihrer herstellung und zusammensetzungen
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
TR200003595T2 (tr) 1998-06-05 2001-07-23 Astrazeneca Ab Kimyasal bileşikler
IL144669A0 (en) * 1999-02-01 2002-05-23 Upjohn Co Process to prepare cyclic-sulfur fluorine containing oxazolidinones
SI1149089T1 (en) * 1999-02-01 2003-10-31 Pharmacia & Upjohn Company PROCESS TO PREPARE TETRAHYDROTHIOPYRAN-o-FLUORINATED CARBAMATES
MY120189A (en) 1999-11-04 2005-09-30 Upjohn Co Sultam and sultone derived oxazolidinones
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
PL356478A1 (en) * 1999-12-21 2004-06-28 Pharmacia & Upjohn Company Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
PE20020044A1 (es) 2000-06-16 2002-01-30 Upjohn Co Tiazina oxazolidinona
PT1301207E (pt) 2000-06-30 2005-11-30 Pharmacia & Upjohn Co Llc Composicoes para o tratamento de infeccoes bacterianas que contem um composto de oxazolidinona, sulbactam e ampicilina
ES2268011T3 (es) * 2001-04-07 2007-03-16 Astrazeneca Ab Oxazolidinonas que contienen un grupo sulfonimida como antibioticos.
GB0108764D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
NZ528996A (en) * 2001-04-20 2006-01-27 Upjohn Co Process to prepare oxazolidinones
WO2002085865A1 (en) 2001-04-20 2002-10-31 Pharmacia & Upjohn Company A method for the preparation of oxazolidinones
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US7049443B2 (en) * 2001-07-12 2006-05-23 Pharmacia & Upjohn Company Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
BR0307103A (pt) * 2002-01-24 2004-12-28 Upjohn Co Dihidrotiazina e dihidrotiopirano oxazolidinovas antimicrobianas
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
CA2476545A1 (en) * 2002-03-29 2003-10-16 Pharmacia & Upjohn Company Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
WO2003097640A1 (en) * 2002-05-22 2003-11-27 Orchid Chemicals & Pharmaceuticals Ltd. Oxazolidinone derivatives as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
EP1539745B1 (de) * 2002-08-12 2006-03-29 Pharmacia & Upjohn Company LLC N-aryl-2-oxazolidinone und deren derivate
BR0316483A (pt) * 2002-11-21 2005-10-11 Upjohn Co Derivados de n-(4-(piperazin-1-il)-fenil-2-oxazolidinona-5-carboxami da e compostos relacionados como agentes antibacterianos
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
EP1594494A1 (de) * 2003-02-07 2005-11-16 Warner-Lambert Company LLC Mittels bizyklischem ring n-substituierte oxazolidinon-derivate zur verwendung als antibakterielle wirkstoffe
EP1594865A2 (de) * 2003-02-07 2005-11-16 Warner-Lambert Company LLC Antibakterielle mittel
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
EP1625124A1 (de) * 2003-05-06 2006-02-15 Ranbaxy Laboratories, Ltd. Oxazolidinonderivate als antimikrobiellen wirkstoff
WO2004113329A1 (en) * 2003-06-20 2004-12-29 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US7265140B2 (en) 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2005082892A2 (en) * 2004-02-17 2005-09-09 Dr. Reddy's Laboratories Ltd. Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
MX2007001568A (es) * 2004-08-06 2007-04-16 Pharmacia & Upjohn Co Llc Oxindol oxazolidinonas como agentes antibacterianos.
EP1685841A1 (de) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prophylaxe und Behandlung von thrombolischen Erkrankungen
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
SG166126A1 (en) 2005-10-04 2010-11-29 Bayer Schering Pharma Ag Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo- 3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
CN101460495B (zh) 2006-03-31 2013-08-14 财团法人乙卯研究所 具有杂环的化合物
US7875958B2 (en) * 2006-09-27 2011-01-25 Taiwan Semiconductor Manufacturing Company, Ltd. Quantum tunneling devices and circuits with lattice-mismatched semiconductor structures
WO2008143649A2 (en) * 2006-12-04 2008-11-27 Dr. Reddy's Laboratories Limited Novel oxazolidinone compounds as antiinfective agents
US7978614B2 (en) * 2007-01-11 2011-07-12 Foundry Network, LLC Techniques for detecting non-receipt of fault detection protocol packets
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
EP2233484A3 (de) 2007-10-02 2012-04-04 Research Foundation Itsuu Laboratory Oxazolidinonderivate mit einem 7-gliedrigem Heteroring
KR101023174B1 (ko) * 2008-09-24 2011-03-18 주식회사 레고켐 바이오사이언스 사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
US8841306B2 (en) 2008-11-20 2014-09-23 Panacea Biotec Ltd. Antimicrobials
CA2810478A1 (en) * 2010-09-07 2012-03-15 Symed Labs Limited Processes for the preparation of 4-{4-[5(s)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one
AR093396A1 (es) * 2012-11-09 2015-06-03 Syngenta Participations Ag Derivados de dihidrotiofeno como compuestos insecticidas
WO2020147504A1 (en) * 2019-01-18 2020-07-23 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
MX2023014197A (es) 2021-06-16 2024-01-18 Celgene Corp Compuestos de azetidinilo que comprenden un grupo de acido carboxilico para el tratamiento de enfermedades neurodegenerativas.
CN115724823B (zh) * 2021-08-27 2023-11-24 中国科学院大连化学物理研究所 一种制备二氢噻吩衍生物的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1250538A (de) * 1969-03-18 1971-10-20
FR2356422A1 (fr) * 1976-03-01 1978-01-27 Delalande Sa Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
FR2380780A2 (fr) * 1977-02-22 1978-09-15 Delalande Sa Application en therapeutique des hydroxymethyl-5 oxazolidinones-2, notamment comme antidepresseurs
FR2500450A1 (fr) * 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
JPS59118721A (ja) * 1982-12-25 1984-07-09 Nippon Zeon Co Ltd カルボキシル化合物の製造方法
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
FR2574796B1 (fr) * 1984-12-18 1990-11-02 Kaseihin Cy Inc C S Procede de preparation de composes d'isocyanate contenant du silicium
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5130316A (en) * 1988-07-29 1992-07-14 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazlidinyl arylbenzene derivatives useful as antibacterial agents
CA2119556C (en) * 1991-11-01 2004-07-06 Michael Robert Barbachyn Substituted aryl- and heteroaryl-phenyloxazolidinones
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5668286A (en) * 1994-03-15 1997-09-16 Pharmacia & Upjohn Company Oxazolidinone derivatives and pharmaceutical compositions containing them
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425609A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
RU2175324C2 (ru) * 1995-09-01 2001-10-27 Фармация Энд Апджон Компани Фенилоксазолидиноны, имеющие с-с-связь с 4-8-членными гетероциклическими кольцами
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
ATE293609T1 (de) * 1997-05-30 2005-05-15 Upjohn Co Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
GB9717807D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
IL144669A0 (en) * 1999-02-01 2002-05-23 Upjohn Co Process to prepare cyclic-sulfur fluorine containing oxazolidinones
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
PL325152A1 (en) 1998-07-06
HUP9901979A3 (en) 2000-03-28
ES2165516T3 (es) 2002-03-16
US6358942B1 (en) 2002-03-19
KR100463772B1 (ko) 2005-11-09
US20050054683A1 (en) 2005-03-10
SK19598A3 (en) 1998-11-04
CZ49398A3 (cs) 1998-08-12
US6166056A (en) 2000-12-26
HUP9901979A2 (hu) 2000-02-28
CN1072222C (zh) 2001-10-03
WO1997009328A1 (en) 1997-03-13
FI980452A0 (fi) 1998-02-27
CA2228647A1 (en) 1997-03-13
DE69616366T2 (de) 2002-07-04
AU716493B2 (en) 2000-02-24
ZA966935B (en) 1998-02-16
ATE207487T1 (de) 2001-11-15
PL186524B1 (pl) 2004-01-30
KR19990044238A (ko) 1999-06-25
DK0856002T3 (da) 2002-02-11
FI980452A (fi) 1998-02-27
MX9801578A (es) 1998-08-30
US6313307B1 (en) 2001-11-06
TW419468B (en) 2001-01-21
EP0856002B1 (de) 2001-10-24
US6043266A (en) 2000-03-28
NO980855D0 (no) 1998-02-27
RU2175324C2 (ru) 2001-10-27
JPH11512386A (ja) 1999-10-26
BR9610474A (pt) 1999-03-02
PT856002E (pt) 2002-04-29
EP0856002A1 (de) 1998-08-05
HK1014946A1 (en) 1999-10-08
AU6718196A (en) 1997-03-27
NO311520B1 (no) 2001-12-03
NZ315469A (en) 2000-01-28
NO980855L (no) 1998-04-30
US5968962A (en) 1999-10-19
CN1197457A (zh) 1998-10-28
US6051716A (en) 2000-04-18
SK283487B6 (sk) 2003-08-05
UA52620C2 (uk) 2003-01-15

Similar Documents

Publication Publication Date Title
DE69616366D1 (de) Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen
AU636012B2 (en) N-(4-piperidinyl)(dihydrobenzofuran or dihydro-2h-benzopyran )carboxamide derivatives
HUT67648A (en) Process for producing novel imidazole and pyrimidine derivatives and pharmaceutical copositions containing them
HUT62280A (en) Process for producing benzofuran, benzothiophene, indole and indolizine derivatives and pharmaceutical compositions comprising same
IL115572A0 (en) Novel substituted 4-(azanaphthoylamino)-piperidines salts of these and pharmaceutical compositions containing them
ATE323080T1 (de) Chinolyl-propylpiperidinderivate und deren verwendung als antimikrobielles mittel
AU2003250206A1 (en) Herbicidal agents containing benzoylpyrazoles and safeners
HU903233D0 (en) Process for producing new 4,4-disubstituted piperidine derivatives
NO955104D0 (no) Anvendelse av 5-acyl-1,4-dihydropyridiner
TW325474B (en) Pyrazol-4-ylbenzoyl derivatives
AU1004195A (en) Hydrazone derivatives
ZA972324B (en) Novel herbicides.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee